Title : Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen.

Pub. Date : 2005 Jul 1

PMID : 15958845






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. Didanosine CD4 molecule Homo sapiens
2 In this study, the dynamics of CD4 cell depletion during tenofovir/didanosine co-administration were analysed. Didanosine CD4 molecule Homo sapiens
3 Cox analysis showed that the CD4 cell decrease was associated with a duration of treatment by didanosine of more than 853 days and a didanosine dose of more than 5.50 mg/kg. Didanosine CD4 molecule Homo sapiens
4 Cox analysis showed that the CD4 cell decrease was associated with a duration of treatment by didanosine of more than 853 days and a didanosine dose of more than 5.50 mg/kg. Didanosine CD4 molecule Homo sapiens